| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Agaricoglyceride | Agaricoglyceride A | VL5570001 | View CAS 557099-51-1 |
| Agaricoglyceride | Agaricoglyceride B | VL5570002 | View CAS 557099-52-2 |
| Agaricoglyceride | Agaricoglyceride C | VL5570003 | View CAS 887478-85-5 |
| Agaricoglyceride | Agaricoglyceride D | VL5570004 | View CAS 887478-86-6 |
[rfq_list]
| Catalogue No. | VL5570001 |
| CAS No. | 557099-51-1 |
| Molecular Formula | C24H14Cl6O9 |
| Molecular Weight | 659.1 g/mol |
| Parent drug | Agaricoglyceride |
| IUPAC Name | 2, 3-bis[(3, 5-dichloro-4-hydroxybenzoyl)oxy]propyl 3, 5-dichloro-4-hydroxybenzoate |
| Synonyms | N/A |
| References | Stadler, Marc, et al. “Novel Analgesic Triglycerides from Cultures of Agaricus Macrosporus and Other Basidiomycetes as Selective Inhibitors of Neurolysin.” The Journal of Antibiotics, vol. 58, no. 12, Dec. 2005, pp. 775–86, https://doi.org/10.1038/ja.2005.105. |
| Status | In-stock |
| ListName | Agaricoglyceride A |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
